Home Economics How Activist Hedge Funds 'On Steroids' Have Become A Boardroom Enemy

How Activist Hedge Funds 'On Steroids' Have Become A Boardroom Enemy

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.



Bill Ackman was running late for the conference. The private jet carrying the billion-dollar New York activist investor to Canada was in a queue at the Toronto airport. No matter. The hundreds of Bay Street businesspeople and reporters who crowded into the main conference room at the Toronto Board of Trade in mid October were almost…

How activist hedge funds ‘on steroids’ have become a boardroom enemy

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Editor
Investing

Which Stocks Should You Buy, and Sell, in 2026?

Dave Kovaleski6 months

Also, the 3 sectors that Wall Street analysts are most bullish about. The usual suspects dominated in 2025 as both the Communication Services and Information Technology sectors helped boost the...